Assessment of Circulating Tumor Cells and Serum Markers for Progression-free Survival Prediction in Metastatic Breast Cancer: a Prospective Observational Study

被引：0
|
作者：
Pierga, J. Y. [1 ]
Hajage, D. [2 ]
Bachelot, T. [3 ]
Delaloge, S. [4 ]
Brain, E. [5 ]
Campone, M. [6 ]
Cottu, P. H. [1 ]
Beuzeboc, P. [1 ]
Rolland, E. [2 ]
Bidard, F. C. [1 ]
机构：
[1] Inst Curie, Dept Med Oncol, Paris, France
[2] Inst Curie, Dept Biostat, Paris, France
[3] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France
[4] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[5] Inst Curie, Dept Med Oncol, St Cloud, France
[6] Inst Cancerol Ouest, Nantes, France
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [1] Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study
    François-Clément Bidard
    David Hajage
    Thomas Bachelot
    Suzette Delaloge
    Etienne Brain
    Mario Campone
    Paul Cottu
    Philippe Beuzeboc
    Emilie Rolland
    Claire Mathiot
    Jean-Yves Pierga
    Breast Cancer Research, 14
  • [2] Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study
    Bidard, Francois-Clement
    Hajage, David
    Bachelot, Thomas
    Delaloge, Suzette
    Brain, Etienne
    Campone, Mario
    Cottu, Paul
    Beuzeboc, Philippe
    Rolland, Emilie
    Mathiot, Claire
    Pierga, Jean-Yves
    BREAST CANCER RESEARCH, 2012, 14 (01):
  • [3] Prospective Assessment of Circulating Tumor Cells and Serum Markers for PFS Prediction in Metastatic Breast Cancer.
    Bidard, F-C
    Hajage, D.
    Bachelot, T.
    Delaloge, S.
    Brain, E.
    Campone, M.
    Cottu, P.
    Beuzeboc, P.
    Mathiot, C.
    Pierga, J-Y
    CANCER RESEARCH, 2011, 71
  • [4] Circulating Tumor Cells in Metastatic Breast Cancer: Monitoring Response to Chemotherapy and Predicting Progression-Free Survival
    Cheng, Jian-ping
    Yan, Ying
    Wang, Xiang-yi
    Lu, Yuan-li
    Yuan, Yan-hua
    Wang, Xiao-li
    Jia, Jun
    Ren, Jun
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (03) : 201 - 210
  • [5] Circulating Tumor Cells in Metastatic Breast Cancer:Monitoring Response to Chemotherapy and Predicting Progression-Free Survival
    Jian-ping Cheng
    Department of Medical Oncology
    Chinese Journal of Cancer Research, 2010, 22 (03) : 201 - 210
  • [6] Circulating tumor cells in metastatic breast cancer: Are they a strong and independent predictor of poor progression-free and overall survival?
    Wallwiener, Markus
    Schneeweiss, Andreas
    Baccelli, Irene
    Riethdorf, Sabine
    Pantel, Klaus
    Marme, Frederik
    Schott, Sarah
    Trumpp, Andreas
    Taran, Florin-Andrei
    Hahn, Markus
    Schuetz, Florian
    Mueller, Volkmar
    Rack, Brigitte Kathrin
    Sohn, Christof
    Solomayer, Erich-Franz
    Janni, Wolfgang
    Hartkopf, Andreas D.
    Fehm, Tanja N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
    Cohen, Steven J.
    Punt, Cornelis J. A.
    Iannotti, Nicholas
    Saidman, Bruce H.
    Sabbath, Kert D.
    Gabrail, Nashat Y.
    Picus, Joel
    Morse, Michael
    Mitchell, Edith
    Miller, M. Craig
    Doyle, Gerald V.
    Tissing, Henk
    Terstappen, Leon W. M. M.
    Meropol, Neal J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) : 3213 - 3221
  • [8] Capecitabine maintaining treatment improves progression-free survival in metastatic breast cancer: A prospective observational study of 669 cases
    Ouyang, Quchang
    Hu, Zhe-Yu
    Yang, Xiaohong
    Liu, Liping
    Li, Jing
    Xiao, Huawu
    Gao, Jianxiang
    Lu, Jun
    Wu, Hui
    Xie, Ning
    Hu, Xuming
    Tian, Can
    Shui, Zhengrong
    Cao, Min
    CANCER RESEARCH, 2021, 81 (04)
  • [9] Circulating tumor cells - Not serum tumor markers - Predict survival in metastatic breast
    Stopeck, A
    Cristofanilli, M
    Budd, GT
    Ellis, MJ
    Matera, J
    Miller, MC
    Doyle, GV
    Allard, WJ
    Terstappen, LW
    Hayes, DF
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 840S - 840S
  • [10] Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naive Prostate Cancer
    Josefsson, Andreas
    Linder, Anna
    Site, Despina Flondell
    Canesin, Giacomo
    Stiehm, Anna
    Anand, Aseem
    Bjartell, Anders
    Damber, Jan-Erik
    Welen, Karin
    PROSTATE, 2017, 77 (08): : 849 - 858
12345